FolioLanternBeta
ARQTArcutis Biotherapeutics, Inc.

Terrie Curran

Director at Arcutis Biotherapeutics, Inc., as of Aug 28, 2026Sold $984K of stock in the past 12 months: 100% with no plan disclosed.

Updated Oct 16, 2026 from SEC filings · covers Oct 17, 2025 to Oct 16, 2026
39K
shares sold, past 12 months
2
days with sales
$956K
largest single day, Aug 27, 2026
1
company filed for

Share of stake sold and shares held at Arcutis Biotherapeutics, Inc. are being verified and not shown yet. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

No plan disclosedOne dollar scale for every month; the tallest bar is labeled
OctNovDecJanFebMarAprMayJunJulAug 2026: $984K no plan disclosed$984KAugSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Arcutis Biotherapeutics, Inc. (ARQT)DirectorNov 4, 2020Aug 28, 2026

Recent filings

The last 3 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.